Aveo finally earns approval for kidney cancer drug
March 10, 2021 at 18:05 PM EST
The Boston-based company announced Wednesday that the drug, tivozanib, has earned approval by the U.S. Food and Drug Administration to treat kidney cancer, ending a long and tumultuous journey.